Archer-Daniels-Midland Company ADM ← Back to all reports

Archer-Daniels-Midland Company

ADM · Consumer Staples
B ★★★ Hold
Aug 7, 2026 · Score 76 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $78.06
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $72.00 ($68.00–$76.00)
Price TargetOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $95.00
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+21.7%

Type A - Archer-Daniels-Midland Company (ADM) 20260807 Stock Analysis

📅 ADM Key Upcoming Events

🏢 Step 1: ADM Company Overview & Business Model

Q1-A1. What is ADM?

Q1-A2. How Does ADM Make Money?

Q1-A3. ADM’s Revenue Segments & Core Income Sources

Q1-A4. Who Are ADM’s Competitors?

Q1-A5. ADM Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: ADM’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does ADM Have a Durable Economic Moat?

Q2-A2. Is ADM’s Growth Sustainable?

Q2-A3. How Does ADM Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is ADM Profitable? Financial Health Analysis

Q3-A2. How Profitable Is ADM? (Margins & ROIC)

Q3-A3. What Drives ADM’s Returns? (ROIC Breakdown)

Q3-A4. Are ADM’s Earnings High Quality?

Q3-A5. Is ADM’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: ADM Forensic Accounting & Dilution Review

Q4-A1. Does ADM Have Accounting Red Flags?

Q4-A2. Is ADM Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is ADM’s Cash Flow?

Q4-A4. Is ADM Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: ADM Management & Shareholder Alignment

Q5-A1. Can You Trust ADM’s Management? (Guidance Track Record)

Q5-A2. What Are ADM Insiders Doing?

Q5-A3. Is ADM’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: ADM Market Flow & Sentiment

Q6-A1. Analyst Consensus vs ADM Guidance

Q6-A2. What Is ADM’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: ADM Catalysts & Price Triggers

Q7-A1. What Could Move ADM Stock? (Top 3 Catalysts)

Q7-A2. ADM’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is ADM Fairly Valued? Valuation Analysis

Q8-A1. ADM’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. ADM vs Peers: Valuation Comparison

Q8-A3. Is ADM Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into ADM? (Reverse DCF)

Q8-A4-1. What Growth Hurdle Does the Market Demand From ADM? (Reverse DCF Alternative)

Q8-A5. Valuation Cross-Check

Q8-A6. ADM’s Hidden Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of ADM? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to ADM?

Q9-A2. How Sensitive Is ADM to the Economy?

Q9-A3. ADM Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score

🎯 Step 10: ADM Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy ADM? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. ADM’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is ADM’s Dependence on Opaque U.S. Biofuel Mandates Its Biggest Weakness?

Q2: Can ADM’s High GAAP P/E Be Justified by the Energy Transition Supercycle?

Q3: How Severely Did the Vikram Luthar SEC Fraud Damage ADM’s Core Culture?

Q4: Will the Decatur East Facility Restart Permanently Fix the Nutrition Segment?

Q5: How Defensible Is ADM’s Position Against Bunge Global’s Aggressive Synergies?

Q6: Can ADM Sustain Its Massive $2.5 Billion Annual Buyback Program?

Q7: Are South American Crop Yields Still the Ultimate Dictator of ADM’s Fate?

Q8: Does the $750 Million Cost-Saving Initiative Mask Underlying Revenue Decay?

Q9: Will Precision Fermentation and Biotics Actually Move the Needle for ADM?

Q10: Is ADM’s 53-Year Dividend Growth Streak at Risk in a Deep Recession?

Rating History

Rating History shows the Rating assigned on each report date. We leave scores out of the timeline because reports from different periods may follow different rating scales. The score remains visible in each report that is still available.

  1. 2026-07 F
  2. 2026-08 B